No summary available
Searching for Solutions
The Lindsay Clancy trial showed reproductive psychiatry’s limitations.
No summary available
Family physicians can safely initiate and optimize buprenorphine treatment in community practice using structured but flexible approaches tailored to fentanyl exposure and patient goals.
Findings provide new insights into co-use of opioids and sedatives and help inform prevention strategies.
The higher prevalence of non-fatal overdose with opioids and stimulants compared to opioids alone across four diverse cohorts has implications for overdose prevention efforts.
In this sample of US pediatric prescribers, buprenorphine prescribing history was more strongly associated with legal clarity, and practice characteristics, and beliefs about MOUD than with clinician type.
After long-term BUP-XR treatment, discontinuation was effective and well tolerated over 6 months.
This retrospective cohort study used deidentified electronic health records (EHR) data linked with administrative claims from the Optum Labs Data Warehouse.
This systematic review and meta-analysis aims to address the literature gap and public health implications of ONP use.
No summary available
"Research shows that limiting access to lethal means is one of the most promising approaches to save lives. It can involve erecting barriers on buildings and bridges to prevent people from jumping, as well as decreasing the number of pills someone can buy or be prescribed at once. And reducing access to guns."
We can do more to prevent suicides in the pharmacy workforce by improving mental health conditions, increasing awareness of suicide risk, and supporting those in need. In recognition of Pharmacy Workforce Suicide Awareness Day, we are proud to share these resources, including ways to get involved: Well-Being Pharmacy Workforce Suicide Awareness Day - ASHP #PharmacySuicideAwareness
On Sept. 8, the DOL's Employee Benefits Security Administration (EBSA) published new interim guidelines for enforcing treatment limitations under the original 2008 Mental Health Parity and Addiction Equity Act. The Trump administration has signaled intent to create a new proposed rule entirely, but this interim guideline aims to clarify enforcement of the nonquantitative treatment limitation (NQTL) requirements in the meantime.
On Thursday, September 17, 2026, the Joint Commission of Pharmacy Practitioners (JCPP) convened leaders of national pharmacy organizations in Alexandria, Virginia, to explore healthcare megatrends shaping the future of pharmacy practice. AAPP was represented by AAPP President Suzie Harris and Executive Director Brenda Schimenti.
PCSS-MOUD added a supplemental course to its SUD 101 Core Curriculum: Managing Common Psychiatric Conditions in Patients with Substance Use Disorders, presented by Ellen L. Edens, MD. Check out this on-demand educational activity!
Sex differences in alcohol consumption following short-term abstinence are likely not explained by changes in AER.
Participants reported high buprenorphine retention and substantial improvements in pain and substance use outcomes, with no overall differences between intervention and control conditions.
Reduction in craving mediates the effect of naltrexone-bupropion pharmacotherapy in MUD.
This study found no convincing evidence for the effectiveness of any pharmacological treatments for cocaine use disorder.
This paper outlines the evolving landscape of integrated care in the United States, including established frameworks that emphasize interdisciplinary teams, clear communication systems, and care coordination across providers.
STARS experts redefine stuttering as a brain-based neuropsychiatric disorder, urging interdisciplinary care.
No summary available
An opinion article on deprescribing and antidepressants.
No summary available